Abstract |
Intravenous (IV) anti-D and IV immunoglobulin ( IVIG) slow the Fcgamma receptor (FcgammaR)-mediated destruction of antibody-coated platelets in patients with immune thrombocytopenic purpura ( ITP). This pilot study explored the mechanism of these immunoglobulin preparations by measuring interleukin-10 (IL-10), monocyte chemoattractant protein-1 (MCP-1), IL-6 and tumour necrosis factor alpha ( TNFalpha), before and after infusion and by assessing the effect of FcgammaRIIa and FcgammaRIIIa polymorphisms on both cytokine and haematologic responses to anti-D. Following IVIG, only IL-10 was increased at 2 h and MCP-1 on day 7 (P < 0.05). In contrast, 2 h after anti-D infusion, plasma levels of all four cytokines were increased (P < 0.01); five of six patients with the highest MCP-1, IL-6 and TNFalpha levels had chills. Higher IL-10 levels correlated with platelet increases at 24 h and haemoglobin decreases at day 7 (P < 0.025). Patients with the FcgammaRIIa-131HH genotype had significantly higher MCP-1, IL-6 and TNFalpha levels. Patients with the FcgammaRIIIa-158VF genotype had higher platelet increments at day 7 (P < 0.05). Soluble CD16 (sCD16) was increased 2 h after IV anti-D; day 7 levels correlated with day 7 haemoglobin decreases (P < 0.01). In conclusion, the relationship of FcgammaRIIa and FcgammaRIIIa polymorphisms with both cytokine levels and platelet increments implicated these receptors in responses to anti-D and supported different mechanisms of FcgammaR interaction to those seen with IVIG.
|
Authors | Nichola Cooper, Nancy M Heddle, Masja Haas, Marion E Reid, Martin L Lesser, Howard B Fleit, B M R Woloski, James B Bussel |
Journal | British journal of haematology
(Br J Haematol)
Vol. 124
Issue 4
Pg. 511-8
(Feb 2004)
ISSN: 0007-1048 [Print] England |
PMID | 14984503
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, CD
- Cytokines
- Fc gamma receptor IIA
- Glucocorticoids
- Immunoglobulins, Intravenous
- Isoantibodies
- RHO(D) antibody
- Receptors, IgG
- Rh-Hr Blood-Group System
- Rho(D) Immune Globulin
- Prednisone
|
Topics |
- Adolescent
- Adult
- Antigens, CD
(genetics)
- Blood Platelets
(immunology)
- Cytokines
(biosynthesis)
- Female
- Glucocorticoids
(therapeutic use)
- Humans
- Immunoglobulins, Intravenous
(therapeutic use)
- Isoantibodies
(adverse effects, therapeutic use)
- Male
- Middle Aged
- Phenotype
- Pilot Projects
- Platelet Count
- Polymorphism, Genetic
- Prednisone
(therapeutic use)
- Purpura, Thrombocytopenic, Idiopathic
(blood, immunology, therapy)
- Receptors, IgG
(genetics)
- Rh-Hr Blood-Group System
(blood)
- Rho(D) Immune Globulin
|